IL6 and Lewy body dementia: Our study, by demonstrating lower CSF IL-6 levels as well as a correlation between IL-6 and α-synuclein in patients with DLB but not in patients with AD, underscores the differences in pathological and disease mechanisms between these two neurodegenerative dementia forms.